These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16170514)

  • 1. Recurrent hepatoblastoma with localization by PET-CT.
    Figarola MS; McQuiston SA; Wilson F; Powell R
    Pediatr Radiol; 2005 Dec; 35(12):1254-8. PubMed ID: 16170514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography in recurrent hepatoblastoma.
    Philip I; Shun A; McCowage G; Howman-Giles R
    Pediatr Surg Int; 2005 May; 21(5):341-5. PubMed ID: 15834579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG positron emission tomography.
    Sironi S; Messa C; Cistaro A; Landoni C; Provenzi M; Giraldi E; Sonzogni A; Fazio F
    AJR Am J Roentgenol; 2004 May; 182(5):1214-6. PubMed ID: 15100121
    [No Abstract]   [Full Text] [Related]  

  • 4. Incremental diagnostic value of F-18 FDG PET/CT over MRI in a pediatric patient with suspected hepatoblastoma and histologic diagnosis of focal nodular hyperplasia.
    Bertagna F; Orlando E; Bosio G; Bercich L; Fisogni S; Grazioli L; Giubbini R
    Clin Nucl Med; 2011 Apr; 36(4):305-8. PubMed ID: 21368608
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of positron emission tomography in detecting hepatoblastoma recurrence--a cautionary tale.
    Wong KK; Lan LC; Lin SC; Tam PK
    J Pediatr Surg; 2004 Dec; 39(12):1779-81. PubMed ID: 15616927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between ¹⁸F-FDG PET/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients.
    Cistaro A; Treglia G; Pagano M; Fania P; Bova V; Basso ME; Fagioli F; Ficola U; Quartuccio N
    Biomed Res Int; 2013; 2013():709037. PubMed ID: 24063012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
    Lin E; Agoff N
    Clin Nucl Med; 2007 Dec; 32(12):949-51. PubMed ID: 18030050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST; Oyen WJ
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of (18)F-FDG PET/CT and CECT in detecting postoperative recurrence and extrahepatic metastasis of hepatocellular carcinoma in patients with elevated serum alpha-fetoprotein].
    Chen Z; Liang H; Zhang X; Wang X; Chen W; Shi X; Yi C; Rao L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Nov; 32(11):1615-9. PubMed ID: 23174588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of FDG-PET/CT in ovarian cancer patients with high tumor markers or suspicious lesion on contrast-enhanced CT in evaluation of recurrence and/or in determination of intraabdominal metastases.
    Sari O; Kaya B; Kara PO; Gedik GK; Celik C; Ozbek O; Serdengecti M
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):3-8. PubMed ID: 21549452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.
    Panagiotidis E; Datseris IE; Exarhos D; Skilakaki M; Skoura E; Bamias A
    Nucl Med Commun; 2012 Apr; 33(4):431-8. PubMed ID: 22293498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.
    Han AR; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2009; 56(93):1111-6. PubMed ID: 19760952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
    Donswijk ML; Hess S; Mulders T; Lam MG
    PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ¹⁸F-Fluorodeoxyglucose positron emission tomography/computed tomography finds answers in cancer patients with increasing tumor markers and negative or equivocal conventional imaging modalities.
    Salem SS; Shahin MA
    Nucl Med Commun; 2012 Mar; 33(3):313-21. PubMed ID: 22237387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tl-201 positive, Ga-67 negative hepatoblastoma: a case report of a 12-year-old boy.
    Bernard EJ; Nicholls W; Howman-Giles R; Kan A; Stevens M
    Clin Nucl Med; 1997 Dec; 22(12):835-7. PubMed ID: 9408645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
    Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
    Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.